Publications by authors named "A Sebnem Soysal"
Introduction: Intravenous immunoglobulin (IVIG) is an alternative for post-exposure prophylaxis if a vaccine is contraindicated and intramuscular immunoglobulin is unavailable. We retrospectively examined the effect of IVIG administration time on measles development in measles-contact infants younger than 6 months of age.
Methodology: Contact tracing of measles cases was performed by the Istanbul Public Health Directorate (IPHD) between August 24, 2012, and June 16, 2013.
Background: The relationship between coronavirus disease 2019 (COVID-19) infection and multiple sclerosis (MS) relapse and disease progression remains unclear. Previous studies are limited by small sample sizes and most lack a propensity-matched control cohort.
Objective: To evaluate the effect of COVID-19 infection on MS disease course with a large propensity-matched cohort.
Article Synopsis
- Stigma in multiple sclerosis (MS) leads to negative outcomes such as anxiety, depression, and social isolation, although there's currently no specific scale to measure it.
- The study aimed to create and validate a "Multiple Sclerosis Stigma Scale (MSSS)" through a three-phase methodological approach, which included defining stigma, generating items, and testing the scale's psychometric properties.
- The final 12-item MSSS showed strong reliability and validity in assessing stigma, revealing two main factors: discrimination and disclosure, making it suitable for use with Turkish MS patients.
Background And Objectives: Women with multiple sclerosis (MS) are at risk of disease reactivation in the early postpartum period. Ocrelizumab (OCR) is an anti-CD20 therapy highly effective at reducing MS disease activity. Data remain limited regarding use of disease-modifying therapies (DMTs), including OCR, and disease activity during peripregnancy periods.
View Article and Find Full Text PDFA multicenter multinational study to evaluate different aspects of the relationship between MS and pregnancy.
Mult Scler Relat Disord
November 2024
Background: To investigate the pregnancy-related issues in females with multiple sclerosis (MS) from Turkiye, Egypt, Kuwait, and Iran.
Methods: 1692 pregnancies of 701 females with MS were evaluated in this retrospective multicenter, international project. Demographics, clinical features, pregnancy outcomes, relapses, effects of exposure to disease-modifying drugs on pregnancy and fetus, and worries about pregnancy decisions were investigated.